ReviewAPMIS : acta pathologica, microbiologica, et immunologica Scandinavica2026
Familial Adenomatous Polyposis-Risk of Cancer, Cancer Prevention, and Long-Term Consequences: Learnings from Five Decades with the Danish Polyposis Register.
Review in APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Familial Adenomatous Polyposis-Risk of Cancer, Cancer Prevention, and Long-Term Consequences: Learnings from Five Decades with the Danish Polyposis Register.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Familial adenomatous polyposis (FAP) is a hereditary condition marked by the growth of hundreds to thousands of adenomatous polyps in the colon and rectum, significantly elevating the risk of colorectal cancer (CRC) if left untreated. Caused by pathogenic variants in the APC gene, FAP is typically identified in adolescence, often leading to the recommendation of prophylactic colectomy to reduce the risk of CRC. However, even with colectomy, FAP patients face higher risks for other cancers, notably in the duodenum and pancreas. Our studies emphasize the importance of lifelong endoscopic surveillance and tailored treatment strategies to detect and manage precancerous lesions in the gastrointestinal tract. Advances in genetic screening have also significantly improved early detection and family risk management, especially for at-risk relatives. The Danish Polyposis Register, for example, is a comprehensive, nationwide database enabling tracking and preventative care for FAP families, effectively prolonging life expectancy by facilitating early intervention and surveillance of cancer risks. Endoscopic evaluation may differentiate between classical FAP and attenuated FAP (AFAP), a milder form with fewer polyps and a delayed onset, although both types require consistent monitoring due to elevated cancer risks. Innovations in genetic research, including the use of whole-genome sequencing, continue to refine risk assessments, helping to prevent unnecessary surgical interventions while providing personalized management plans for each patient. The disease's impact extends beyond physical health; the hereditary nature of FAP leads to psychological stress, often resulting in higher anxiety, depression, and educational challenges among patients. Adolescents and young adults, in particular, might benefit from targeted psychological support and educational interventions to help manage the mental and social implications of living with a chronic, cancer-prone condition. Studies underscore the need for interdisciplinary care to support these aspects of patients' lives, as they face unique challenges not experienced by other populations. Overall, research suggests that FAP treatment must integrate comprehensive cancer surveillance, proactive genetic screening, mental health support, and tailored medical interventions. The success of multidisciplinary, national registers like Denmark's emphasizes the importance of such models worldwide and should encourage the development of similar programs to improve patient outcomes and support those at high risk for hereditary cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.